2025 Updates in Care of the Hematologic Malignancies Patient: with Proceedings from International Medical Meetings

---

LIVECMECNE

Friday, January 17, 2025, 7:00 AM - 4:00 PM, Hilton Hotel Philadelphia City Avenue, Philadelphia, PA

This course is a comprehensive review of hematologic malignancies focusing on research developments over the preceding year and their application to the patient care journey. Didactic presentations will include case discussion with Penn faculty and community experts. Activity format will provide significant opportunity for interaction with expert faculty and other attendees with the aim of implementing new standards of patient care. Participants will leave with up-to-date, practical information which will have immediate clinical application.

1. Evaluate evolving treatment strategies for mantle cell lymphoma.
2. Explain equal access to transplant and the use of mismatched donors
3. Describe cell therapy approaches for autoimmune diseases.
4. Analyze progress in GVHD therapies.
5. Evaluate emerging treatment options for AML.
6. Apply current management of MDS and bone marrow failure syndromes.
7. Summarize updates in CML and myeloproliferative disease.
8. Analyze current and future immunotherapies for acute leukemias (including CD33 CAR T-cell therapy).
9. Explain current approaches to smoldering myeloma and amyloidosis.
10. Review initial therapy for multiple myeloma, including the role of transplant.
11. Evaluate the role of immunotherapy in myeloma treatment.
12. Analyze investigational therapies for relapsed myeloma.

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 7.25 Category 1 credits for completing this activity.

Nurses: This program provides 7.25 NCPD Hours.

ABS MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn 7.25 credits toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

AMA PRA Category 1 Credits™ (7.25 hours), NCPD Hours (ANCC) (7.25 hours), Non-Physician Attendance / Participation (7.25 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, January 17, 2025